The first two of the genes upregulated with elevated pressure in the
TM, IL-6 and SP, are well-known markers of
inflammation.
27 28 One of the important actions of these
two molecules is their ability to increase vascular permeability in
vitro
29 30 31 and in vivo.
32 33 34 This effect
may be produced by mechanisms such as the induction of intercellular
gaps,
31 34 increased number of pinocytic vesicles and
vacuoles,
35 and release of ECM
proteinases.
36 37 IL-6 can be induced by
ROS,
38 cyclic adenosine monophosphate
(cAMP),
39 forskolin,
40 transforming growth
factor beta
41 and bradykinin,
42 and it is
noteworthy that most of these agents also influence aqueous humor
outflow facility.
42 43 44 45 46 47 SP can be induced by noxious
stimuli and in turn promote the release of prostaglandin
E
2,
48 inflammatory cytokines
(including IL-6),
49 and superoxide.
50 Initially considered to be exclusively of neuronal
origin,
51 SP has been subsequently identified in a variety
of nonneuron cell types.
52 53 54 In the eye, SP has been
described inside the nerves of ocular tissues, including those of the
TM.
55 56 57 Because our organ culture tissue preparation
would exclude neuronal bodies, our results suggest a potential
endogenous production of this peptide by TM cells. Interestingly, human
umbilical vein endothelial cells release SP in response to increased
flow.
58